The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Significance of imaging-detected extranodal extension (iENE) in locally advanced head and neck squamous cell carcinoma (LASCCHN) treated with induction chemotherapy followed by chemoradiotherapy.
 
Ryutaro Onaga
No Relationships to Disclose
 
Tomohiro Enokida
Honoraria - Bayer; Merck/Eisai; MSD; Ono Pharmaceutical
 
Takashi Hiyama
No Relationships to Disclose
 
Nobukazu Tanaka
No Relationships to Disclose
 
Yuta Hoshi
No Relationships to Disclose
 
Hideki Tanaka
No Relationships to Disclose
 
Takao Fujisawa
Honoraria - Amelief; Merck Serono
 
Susumu Okano
Speakers' Bureau - Bristol-Myers Squibb Japan; Meiji Seika Kaisha; Merck Serono; MSD; Ono Pharmaceutical
 
Hirofumi Kuno
No Relationships to Disclose
 
Makoto Tahara
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD; Novartis; Ono Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Genmab; GlaxoSmithKline; Janssen; Lilly; Merck KGaA; MSD; Nanobiotix; Ono Pharmaceutical; Pfizer; Rakuten Medical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Rakuten Medical (Inst)